Terttu Haring’s Post

Artificial Intelligence (AI) has the exciting potential to accelerate Clinical Research. This also will ask courage of us all to experiment with AI, learn and improve... Here's a glimpse into how AI is revolutionizing the landscape: 1.    Accelerated Drug Discovery: AI-driven algorithms analyze vast datasets to predict drug-target interactions, expediting the identification and validation of potential compounds, ultimately streamlining the drug discovery process. 2.    Precision Medicine and Personalized Treatment: AI empowers researchers to analyze genetic, molecular, and clinical data to identify biomarkers, enabling the development of personalized therapies tailored to individual patient profiles, enhancing treatment efficacy. 3.    Enhanced Clinical Trial Design: AI algorithms optimize trial design by identifying suitable patient populations, predicting patient responses, and refining protocols, leading to more efficient trials with improved success rates. 4.    Real-time Data Analysis: AI enables real-time analysis of patient data, facilitating remote monitoring, early detection of adverse events, and dynamic adjustments in treatment strategies, ensuring quicker interventions and better patient outcomes. 5.    Predictive Analytics for Patient Recruitment: Leveraging machine learning models assists in identifying eligible candidates for clinical trials based on comprehensive patient profiles, enhancing recruitment efficiency and diversifying participant pools. The integration of AI in Clinical Research isn't just a trend; it's a game-changer, reshaping how we approach research and patient care. Curious to learn more about how AI is revolutionizing our field? Let's connect and explore this fascinating intersection further. #AI #ClinicalResearch Also watch last months's interesting Syneos webinar on AI supercharging clinical research;

AI in Clinical Trials is not coming, it’s already here! This recorded Webinar is definitely worth a watch:

Predictions for the Life Sciences 2024: Science and Technology: Data Sharing and Cross-Industry Collaboration Data sharing and cross-industry collaboration will power the 2024 AI revolution in clinical research. No one company has enough data to drive accurate productions around a single disease or use case, which is why cross-industry collaboration like we witnessed during the pandemic will be reinvigorated.  -- Rohit Nambisan Article by Chris Slawecki of DRUG INFORMATION ASSOCIATION (DIA) Read here 👉 https://lnkd.in/gAdYcz4b #clinicaltrials #clinicalresearch

Through WELL's strategic partnership with HEALWELL AI, Pentavere's majority shareholder, we're leading the charge in driving healthcare innovation forward! Pentavere is a leading Patient Identification Company that has built a breakthrough #AI engine to identify patients eligible for approved medications or interventions, improving patient outcomes and helping drive therapy growth and penetration. Check out 20Sense | Consulting's recent article highlighting how Pentevere's AI engine, DARWEN, transforms electronic health records into actionable insights, identifying diseases from physician clinical notes. Read the article below. https://ow.ly/H24X50QYcIG #RareDisease #HealthcareAI

🚀 AI in Clinical Trials: 5 Urgent Facts You Need to Know Right Now in 2024 🤖 AI is revolutionizing clinical trials in ways we never imagined. From accelerating drug development to improving patient recruitment and data accuracy, AI is reshaping the future of healthcare in 2024. Swipe through to discover how AI is cutting trial times, reducing costs, and driving better outcomes! 📊✨ Share Your Thoughts! #AIinHealthcare #ClinicalTrials #InnovationInMedicine #FutureOfHealthcare #PharmaInnovation #ArtificialIntelligence #ClinicalResearch #PatientCentric #HealthcareInnovation #AI2024 #MedTech #Pharma #ClinicalTrialSolutions #DataDriven #HealthTech

AI is reshaping clinical research, enabling faster startups and improving cost-effectiveness. Next week at the COG Bay Area Conference, Shae Wilkins will explore how AI can be used in clinical trials and showcase a real-world case study where AI-powered video anonymization helped a sponsor more easily utilize video source data to support a successful FDA submission. Join us to learn how AI-driven tools are unlocking new efficiencies in clinical trials! #ClinicalTrials #VideoAnonymization #eCOA #eConsent #clinicalresearch

The clinical development market faces significant challenges, with rising 💰 costs and development ⌛time, increasing regulatory requirements and low success rates. These challenges highlight the pressing need to advance and improve the efficiency and preciseness of clinical development. 💫 Check this out PhaseV is a technology company innovating clinical development through advanced AI/ML technology. Leveraging proprietary causal machine learning and AI tools and cutting-edge software capabilities, PhaseV's platform enables sponsors to harness all available data to inform crucial decisions in clinical development and design and execute advanced adaptive clinical trials, leading to more efficient, precise, and successful clinical trials. In less than 2 years since its foundation, the company has proven its capabilities and unique value through over 20 customer projects, including with 7 of the 12 top big pharma companies successfully optimizing the clinical development path across multiple therapeutic areas. Dr. Raviv Pryluk, CEO & co-founder will be in San Francisco for the JPM Conference and is looking for more partners and investors who are interested in developing these capabilities and providing a better service to the industry. 📄Please fill out this form if you want to meet with PhaseV team: https://lnkd.in/d7fYjnax 📧 We would be happy to send you more information about the company's offerings, just send us an email to [email protected] #investmentopportunity #digitalhealth #softwaredevelopment Michal Landesman Elad Berkman LionBird Viola Ventures Exor Ventures Sharon Vanek #jpmc25

We are excited to announce that MedChatQA, our innovative solution for healthcare professionals (HCPs) seeking drug information, has reached a significant milestone with over 400 downloads since its launch earlier this year. This achievement underscores our commitment to revolutionizing information access in the healthcare industry. Impact on Healthcare Communication MedChatQA addresses a critical need in the medical field, where precise and error-free information is essential for effective communication between healthcare professionals, patients, and colleagues. Our dataset serves as a benchmark for evaluating large language models (LLMs) in delivering accurate question-and-answer interactions on real-world medical topics. Setting the Standard While we celebrate the growing number of downloads, our primary focus remains on the dataset's impact. MedChatQA aims to establish the gold standard for developing and assessing medical question-answering systems. By enhancing the quality and speed of information access for healthcare professionals, we ultimately contribute to improved patient care. Comprehensive Dataset The MedChatQA dataset is specifically designed to support developers of Generative AI (GenAI) products in the medical sector. It provides a robust tool for testing and validating their models, comprising approximately 30,000 questions covering around 1,000 FDA-approved human prescription drugs. By offering this extensive resource, we are helping to drive innovation and accuracy in medical AI applications, furthering our mission to transform healthcare information accessibility and quality. #ngram

Join me next week on Tuesday at 12:15 pm as I speak on "Uncovering the potential impact of large language models and generative AI on clinical trial efficiency to excel in drug development" at the Embassy Suites in Raleigh. This talk is reflective of Cloud Pharmaceutical's latest work and I am excited to share our insights with you. If you're interested in discussing more about our work and how we can collaborate, shoot me a note to set up a meeting. Looking forward to seeing you there! #ai #generativeai #llm #clinicaltrials #biotechnology #aidrugdiscovery

Special Thanks to Dr. Manthan Mehta for his valuable insights about this Industry. Hustlers, the future is here, and it's powered by AI! Imagine a world where: ✅ Diseases are diagnosed faster than ever. ✅ Drug trials are more efficient and accurate. ✅ Primary care is smarter, accessible, and personalized. Sounds like science fiction? Think again! In our latest Medhustlr video, we dive deep into how Artificial Intelligence is transforming the healthcare landscape, reshaping diagnostics, revolutionizing drug development, and making primary care smarter and more efficient. 💡 If you're a healthcare enthusiast, a curious learner, or someone who's ready to embrace the intersection of medicine and technology, this is your cue. 👉 Watch the video now and get ready to explore the possibilities of AI-driven healthcare innovation. 🧠 Question for you, Hustlers: Where do you see the biggest potential for AI in healthcare? Let’s discuss in the comments below! #AIinMedicine #HealthcareInnovation #MedTech #Medhustlr Link for the video: